Plain-English translation of NCT07087821 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different self-management programs — called UPLIFT and PACES — designed to help people with epilepsy better manage their condition and mood. Researchers want to understand how well these programs work and whether they're worth investing in long-term. You would be randomly assigned to either receive one of these programs or receive standard care, and your progress would be tracked over a year.
Many people with epilepsy struggle with mood symptoms like depression, and these self-management programs have shown promise in helping. However, these programs aren't widely available because we don't yet have clear evidence about their cost-effectiveness and long-term value — this study aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
You would attend visits at baseline (start), and then at 3, 6, and 12 months. At each visit, you'd complete surveys about your mood, seizures, and quality of life, and share information about your healthcare costs. Depending on which group you're randomly assigned to, you'd either participate in one of the self-management programs (which involves learning tools and strategies to manage epilepsy) or receive your usual care plus some extra support. The entire study lasts about one year.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States